GSK Stock Forecast for 2023 - 2025 - 2030

Updated on 05/29/2024

Stock Rating
12
Price Target
£19.95
Consensus
Outperform
Upside
14.66%
Analysts
12
Stock Rating
12
Upside
14.66%
Analysts
12
Price Target
£19.95

GSK Stock Forecast and Price Target

The average price target of £19.95 for GSK's stock set by twelve distinguished analysts in recent weeks would represent a potential upside of approximately 14.66% from the last closing price in May, 2024 if reached by the end of the year. This potential increase is based on a high estimate of £34.79 and a low estimate of £12.00. If you are not interested in GSK stock, you may be interested in its competitors.

£19.95

14.66% Upside

Outperform
Outperform

GSK Fair Value Forecast for 2023 - 2025 - 2030

GSK's Price has decreased In the last four years, from £17.24 to £0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach £18.55 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
£18.55
2025 Fair Value Forecast
£20.69
2026 Fair Value Forecast
£22.95
2027 Fair Value Forecast
£24.49
2028 Fair Value Forecast
£22.23
2029 Fair Value Forecast
£21.05
2030 Fair Value Forecast
£20.57
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ABBV Stock Forecast AbbVie Outperform 9
$155.34 Buy/Sell $178.42 17.48%
AZN Stock Forecast AstraZeneca PLC Outperform 17
£120.28 Buy/Sell £165.99 40.24%
ABT Stock Forecast Abbott Laboratories Outperform 9
$101.95 Buy/Sell $118.92 22.61%
AMGN Stock Forecast Amgen Outperform 4
$300.19 Buy/Sell $303.65 7.36%
CSL Stock Forecast CSL Outperform 12
$281.96 Buy/Sell $205.51 -27.13%

GSK Revenue Forecast for 2023 - 2025 - 2030

GSK's Revenue has decreased In the last three years, from £34.10B to £30.33B – a 11.06% drop. In the next year, analysts believe that Revenue will reach £31.19B – an increase of 2.84%. For the next seven years, the forecast is for Revenue to grow by 13.19%.

2024 Rev Forecast
£31.19B
2025 Rev Forecast
£33.08B
2026 Rev Forecast
£35.11B
2027 Rev Forecast
£36.42B
2028 Rev Forecast
£37.38B
2029 Rev Forecast
£34.99B
2030 Rev Forecast
£34.33B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BMY Stock Forecast Bristol-Myers Squibb Hold 2
$40.49 Buy/Sell $58.15 33.37%
GILD Stock Forecast Gilead Sciences Inc Outperform 11
$63.94 Buy/Sell $87.82 25.12%
CL Stock Forecast Colgate-Palmolive Co Outperform 18
$91.94 Buy/Sell $88.97 7.14%

GSK Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, GSK's Dividend per Share has seen a drop from £1.00 to £0.58 – a 42.00% decrease. In the next year, analysts believe that Dividend per Share will reach £0.61 – an increase of 5.17%. For the next seven years, experts predict that GSK's Dividend per Share will grow at a rate of 22.41%.

2024 DPS Forecast
£0.61
2025 DPS Forecast
£0.65
2026 DPS Forecast
£0.66
2027 DPS Forecast
£0.68
2028 DPS Forecast
£0.66
2029 DPS Forecast
£0.69
2030 DPS Forecast
£0.71
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
4568 Stock Forecast Daiichi Sankyo Company Buy 4
¥5.50k Buy/Sell ¥5.24k 12.83%
BDX Stock Forecast Becton Dickinson and Co Outperform 9
$226.80 Buy/Sell $284.47 23.46%
MMM Stock Forecast 3M Hold 10
$98.68 Buy/Sell $109.39 4.88%

GSK Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
£6.63B
2025 FCF Forecast
£7.29B
2026 FCF Forecast
£7.50B
2027 FCF Forecast
£7.98B
2028 FCF Forecast
£9.49B
2029 FCF Forecast
£9.92B
2030 FCF Forecast
£10.29B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
4519 Stock Forecast Chugai Pharmaceutical Outperform 6
¥4.76k Buy/Sell ¥4.92k 28.04%
ALC Stock Forecast Alcon Outperform 8
CHF80.86 Buy/Sell CHF90.64 19.80%
A Stock Forecast Agilent Technologies Outperform 10
$148.21 Buy/Sell $138.82 1.88%

GSK EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, GSK's EBITDA has fallen from £10.32B to £10.30B – a 0.16% decrease. For the next year, analysts predict that EBITDA will reach £10.62B – an increase of 3.08%. Over the next seven years, experts believe that GSK's EBITDA will grow at a rate of 46.82%.

2024 EBITDA Forecast
£10.62B
2025 EBITDA Forecast
£11.52B
2026 EBITDA Forecast
£12.50B
2027 EBITDA Forecast
£13.20B
2028 EBITDA Forecast
£13.97B
2029 EBITDA Forecast
£14.55B
2030 EBITDA Forecast
£15.13B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BN Stock Forecast Danone Outperform 11
58.78€ Buy/Sell 55.47€ 8.88%
CTVA Stock Forecast Corteva Outperform 12
$55.66 Buy/Sell $61.72 16.78%
ABEV3 Stock Forecast Ambev Outperform 10
R$11.59 Buy/Sell R$15.65 35.89%

GSK EBIT Forecast for 2023 - 2025 - 2030

In the last three years, GSK's EBIT has decreased from £8.44B to £8.40B – a 0.38% drop. In the next year, analysts predict that EBIT will jump to £9.15B – up 8.84% from the current level. Looking ahead to seven years, experts forecast that EBIT will grow by 17.56%.

2024 EBIT Forecast
£9.15B
2025 EBIT Forecast
£10.08B
2026 EBIT Forecast
£11.14B
2027 EBIT Forecast
£11.41B
2028 EBIT Forecast
£10.84B
2029 EBIT Forecast
£10.38B
2030 EBIT Forecast
£9.88B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
HEN3 Stock Forecast Henkel AG & Co. KGaA Hold 16
82.50€ Buy/Sell 71.63€ -1.82%
BEI Stock Forecast Beiersdorf Outperform 17
143.90€ Buy/Sell 137.41€ 3.54%
BAYN Stock Forecast Bayer Hold 5
27.80€ Buy/Sell 45.15€ 7.91%

GSK EPS Price Prediction Forecast for 2023 - 2025 - 2030

GSK's EPS has decreased In the last four years, from £1.45 to £0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach £1.56 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
£1.56
2025 EPS Forecast
£1.74
2026 EPS Forecast
£1.93
2027 EPS Forecast
£2.06
2028 EPS Forecast
£1.87
2029 EPS Forecast
£1.77
2030 EPS Forecast
£1.73
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ADM Stock Forecast Archer-Daniels-Midland Hold 8
$60.89 Buy/Sell $67.70 3.47%
COLO B Stock Forecast Coloplast A/S Hold 18
kr842.40 Buy/Sell kr812.28 6.84%
CHD Stock Forecast Church & Dwight Co Inc Hold 11
$104.16 Buy/Sell $96.90 3.69%